PATENT INFRINGEMENT cases are inevitable in the pharma industry. Lawsuits are filed more often than new drugs are discovered and every modification of a drug results in more patents and, predictably, more infringement suits. These take years to be settled, but since the damages awarded by the courts can be astronomical in the US, well-heeled drug majors have an incentive to pursue aggressive litigation. Legal costs don't matter much to the big firms, since their market monopoly allows them to rake in millions, if not billions, of dollars in profit.
Developments in recent months may well alter the course of litigation, and it could perhaps make the drug patent battles less problematic for Indian generics, for whom the US is the most lucrative market. This is the entry of the US Federal Trade Commission (FTC) in the knotty question of patents. FTC's primary role is to enforce consumer protection laws aimed at preventing fraud and unfair business practices, but it also enforces federal antitrust laws that "prohibit anticompetitive mergers and other business practices that could lead to higher prices, fewer choices, or less innovation." Possibly because of the Joe Biden Administration's interest in bringing down healthcare costs, FTC is now looking at drug patents from the latter aspect.
This story is from the April 01, 2024 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 01, 2024 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
INVISIBLE THREAT
Significant presence of microplastics in Puducherry’s agricultural soil raises concerns for soil and crop health
Feeding off each other
VEGETARIAN MOVEMENTS IN SOUTH ASIA AND THE WEST GREW WITH MUTUAL SUPPORT AND VALIDATION
India's unhealthy patent amendments
Despite strong pleas, the Modi regime has changed the rules to impose a cost on those who challenge faulty patents
URBAN DISCOMFORT
Poorly planned, heat-trapping infrastructure, along with dwindling natural spaces, turn up the temperatures in major Indian cities
BLAZING SUN IS ON
Rising temperatures are testing the limits of human tolerance to heat. With their predominantly built-up landscape, urban areas offer no respite. A study by the Centre for Science and Environment on the morphology and heat patterns of nine Indian cities over the past decade shows how these urban centres are turning into heat islands with a potentially serious impact on human health. An analysis by Rajneesh Sareen, Mitashi Singh and Nimish Gupta, with Shagun in Haryana and Kiran Pandey
"H5N1 may be more severe than COVID-19"
In early April, the US confirmed the first case of avian influenza in livestock, along with cow-to-human transmission of the virus disease.
A PSYCHEDELIC HIGH
Driven by surge in global trials and low success rate of current medications in treating mental health problems, researchers call for home-grown clinical trials of psychedelic drugs
Locked out
Two years after becoming the only state to be excluded from the Centre's ruralemployment guarantee scheme, villages in West Bengal grapple with distress migration and debt traps
'Protection from climate change part of right to life'
The Supreme Court of India, on April 5, recognised that citizens have a right to be free from the adverse effects of climate change, saying it is intertwined with the fundamental rights to life and equality. Here are the key arguments articulated by the three-judge bench of Chief Justice DY Chandrachud and Justices JB Pardiwala and Manoj Misra in their judgement
Weaving dreams
Tribal communities in West Bengal slowly embrace traditional weaving to ensure sustainable livelihood